- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Neurologix Inc+ Add to Watchlist
NRGXQ:US0.0007 USD 0.00000.00%
As of 20:10:00 ET on 12/19/2013.
Company Profile for Neurologix Inc (NRGXQ)
Neurologix, Inc. is developing treatments for disorders of the brain and central nervous system using gene therapy and other alternative therapies. The Company's initial development efforts are focused on gene therapy for treating Parkinson's disease and epilepsy. Neurologix's core technology, NLX, is currently being tested in a human clinical trial to treat Parkinson's disease.
Key Executives for Neurologix Inc (NRGXQ)
|Clark A JohnsonChairman/CEO||Christine V SapanExec VP/Chief Development Ofcr|